These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6232913)

  • 41. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic value of thyrotrophin-releasing hormone in pituitary and hypothalamic diseases. Assessment of thyrotrophin and prolactin secretion in 100 patients.
    Snyder PJ; Jacobs LS; Rabello MM; Sterling FH; Shore RN; Utiger RD; Daughaday WH
    Ann Intern Med; 1974 Dec; 81(6):751-7. PubMed ID: 4372919
    [No Abstract]   [Full Text] [Related]  

  • 44. Brain immunoreactive gonadotropin-releasing hormone in Huntington's chorea and in non-choreic subjects.
    Bird ED; Chiappa SA; Fink G
    Nature; 1976 Apr; 260(5551):536-8. PubMed ID: 131252
    [No Abstract]   [Full Text] [Related]  

  • 45. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
    Corsini GU; Onali P; Masala C; Cianchetti C; Mangoni A; Gessa G
    Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Huntington's chorea and bromocriptine.
    Albano C; Cocito L
    Arch Neurol; 1979 May; 36(5):322. PubMed ID: 156018
    [No Abstract]   [Full Text] [Related]  

  • 47. Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release.
    Caine E; Kartzinel R; Ebert M; Carter AC
    Life Sci; 1978 Mar; 22(10):911-8. PubMed ID: 147978
    [No Abstract]   [Full Text] [Related]  

  • 48. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
    Schlienger JL; Kapfer MT; Singer L; Stephan F
    Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bromocriptine treatment over 12 years in acromegaly: effect on growth hormone and prolactin secretion.
    Rau H; Althoff PH; Schmidt K; Usadel KH
    Acta Endocrinol (Copenh); 1992 Mar; 126(3):247-52. PubMed ID: 1574954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.
    Durso R; Tamminga CA; Ruggeri S; Denaro A; Kuo S; Chase TN
    J Neurol Neurosurg Psychiatry; 1983 Dec; 46(12):1134-7. PubMed ID: 6229607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum thyrotrophin, prolactin and growth hormone, response to TRH during oestrogen treatment.
    Rutlin E; Haug E; Torjesen PA
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):23-35. PubMed ID: 401551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly.
    Hanew K; Sasaki A; Mouri T; Yoshinaga K
    Acta Endocrinol (Copenh); 1980 Nov; 95(3):298-307. PubMed ID: 6776756
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of piracetam in Huntington's chorea.
    Destée A; Petit H; Warot P
    Eur Neurol; 1984; 23(2):89-91. PubMed ID: 6233148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dexamethasone therapy in Huntington chorea: preliminary results].
    Nuti A; Maremmani C; Ceravolo R; Pavese N; Bonuccelli U; Muratorio A
    Riv Neurol; 1991; 61(6):225-7. PubMed ID: 1839936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea.
    Piolti R; Appollonio I; Perego M; Pozzi C; Rovati L; Ferrarese C; Frattola L
    Eur Neurol; 1995; 35(6):344-8. PubMed ID: 8591802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
    Stracke H; Heinlein W; Horowski R; Schatz H
    Arzneimittelforschung; 1986 Dec; 36(12):1834-6. PubMed ID: 3566845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Responses to lisuride in Meige's disease and chorea.
    Micheli F; Fernandez Pardal MM
    Neurology; 1986 Mar; 36(3):445. PubMed ID: 2936984
    [No Abstract]   [Full Text] [Related]  

  • 58. Alcohol and anterior-pituitary secretion.
    Loosen PT; Prange AJ
    Lancet; 1977 Nov; 2(8045):985. PubMed ID: 72332
    [No Abstract]   [Full Text] [Related]  

  • 59. Lisuride in parkinsonism.
    Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low doses of dopamine agonists in the long-term treatment of macroprolactinomas.
    Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG; Cozzi R; Chiodini P; Luccarelli G
    N Engl J Med; 1985 Sep; 313(11):656-9. PubMed ID: 4022058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.